Sympathetic interactions of AT1 receptors

作者: J. C. Balt , M. Pfaffendorf

DOI: 10.1007/978-3-642-18495-6_16

关键词:

摘要: The present chapter deals with the interaction between renin-angiotensin system (RAS) and sympathetic nervous (SNS). Numerous studies have shown that (locally produced) angiotensin II (Ang II), main effector of RAS, can enhance transmission. Ang has been to ganglionic transmission, facilitate NA release from synaptic nerve terminals, block uptake, synthesis, postsynaptic effects noradrenaline. Angiotensin-Converting enzyme (ACE) inhibitors AT1 receptor blockers attenuate facilitating effect on neurotransmission. It is generally believed exerts its neurotransmission through activation receptors. Several new, non-peptidergic AT1-selective are now available. potency these drugs respect attenuation facilitation by subject in several studies, discussed chapter. In some order regarding this sympatho-inhibition differs inhibition direct pressor II. These findings suggest differences affinity for pre- receptor. Sympatho-inhibition a class antagonists. conditions which plays pathophysiological role, such as hypertension congestive heart failure, property may well be therapeutic relevance.

参考文章(110)
Mohan K. Raizada, Di Lu, Colin Sumners, AT1 Receptors and Angiotensin Actions in the Brain and Neuronal Cultures of Normotensive and Hypertensive Rats Advances in Experimental Medicine and Biology. ,vol. 377, pp. 331- 348 ,(1995) , 10.1007/978-1-4899-0952-7_23
J. T. A. Knape, P. A. van Zwieten, Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac β1-adrenoceptors Naunyn-Schmiedeberg's Archives of Pharmacology. ,vol. 338, pp. 185- 190 ,(1988) , 10.1007/BF00174868
R. R. Wexler, A. L. Johnson, D. J. Carini, P. C. Wong, P. B. M. W. M. Timmermans, A. T. Chiu, W. A. Price, J. V. Duncia, Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. Journal of Pharmacology and Experimental Therapeutics. ,vol. 252, pp. 719- 725 ,(1990)
Jose Luis Rodriguez-Garcia, Antonio Paule, Joaquin Dominguez, Jose Ramon Garcia-Escribano, Mercedes Vazquez, Changes in plasma norepinephrine and endothelin levels and metabolic profile after AT1-receptor blockade in human hypertension. American Journal of Cardiology. ,vol. 85, pp. 1147- 1150 ,(2000) , 10.1016/S0002-9149(00)00714-1
Claude R. Benedict, Brent Shelton, David E. Johnstone, Gary Francis, Barry Greenberg, Marvin Konstam, Jeffrey L. Probstfield, Salim Yusuf, Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction Circulation. ,vol. 94, pp. 690- 697 ,(1996) , 10.1161/01.CIR.94.4.690
B Clemson, L Gaul, S S Gubin, D M Campsey, J McConville, J Nussberger, R Zelis, Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. Journal of Clinical Investigation. ,vol. 93, pp. 684- 691 ,(1994) , 10.1172/JCI117021
Serafim Guimarães, Helder Pinheiro, Paula Tavares, Ana Loio, Daniel Moura, Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 363, pp. 509- 514 ,(2001) , 10.1007/S002100100396
Guido Grassi, Carlo Turri, Raffaella DellʼOro, Maria Luisa Stella, Gianni B. Bolla, Giuseppe Mancia, Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. Journal of Hypertension. ,vol. 16, pp. 1789- 1796 ,(1998) , 10.1097/00004872-199816120-00012
Jean-Claude Panisset, Pierre Bourdois, Effect of angiotensin on the response to noradrenaline and sympathetic nerve stimulation, and on 3H-noradrenaline uptake in cat mesenteric blood vessels. Canadian Journal of Physiology and Pharmacology. ,vol. 46, pp. 125- 131 ,(1968) , 10.1139/Y68-021